Anaesthesia as an influence in tumour progression - Top-Institutions - MDSpire

Anaesthesia as an influence in tumour progression

  • By

  • Jadie Plücker

  • Naita M. Wirsik

  • Alina S. Ritter

  • Thomas Schmidt

  • Markus A. Weigand

  • February 1, 2021

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Anaesthesiology
    • Perioperative Medicine
    • Translational Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Anaesthesiology
    • Immunology
    • Perioperative Care

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Anaesthesiology
    • Oncology
    • Perioperative Medicine
    • Molecular Biology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Anaesthesiology
    • Cancer Immunology
    • Perioperative Medicine

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Anaesthesiology
    • Oncology
    • Perioperative Medicine
    • Immunology

Original Source(s)

Anaesthesia as an influence in tumour progression

  • by Jadie Plücker, Naita M. Wirsik, Alina S. Ritter, Thomas Schmidt, Markus A. Weigand

  • February 1, 2021

Related Content

Laparoscopic intracavitary catheterization combined with bleomycin quadruple sclerotherapy for retroperitoneal lymphatic malformations: a single-center case series

Correction: Omentopexy after laparoscopic sleeve gastrectomy in children and adolescents: is it effective in reducing post-operative complications?

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.